James C Blair - Net Worth and Insider Trading
James C Blair Net Worth
The estimated net worth of James C Blair is at least $83 Million dollars as of 2024-06-10. James C Blair is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $54 Million. James C Blair is the Director, 10% Owner of Zogenix Inc and owns about 825,323 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. James C Blair is also the 10% Owner of Esperion Therapeutics Inc and owns about 2,102,188 shares of Esperion Therapeutics Inc (ESPR) stock worth over $6 Million. Besides these, James C Blair also holds Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Orexigen Therapeutics Inc (OREXQ) , Clovis Oncology Inc (CLVSQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) , NuVasive Inc (NUVA) . Details can be seen in James C Blair's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James C Blair has not made any transactions after 2019-08-20 and currently still holds the listed stock(s).
Transaction Summary of James C Blair
James C Blair Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James C Blair owns 31 companies in total, including Clovis Oncology Inc (CLVSQ) , Obalon Therapeutics Inc (OBLN) , and aTyr Pharma Inc (ATYR) among others .
Click here to see the complete history of James C Blair’s form 4 insider trades.
Insider Ownership Summary of James C Blair
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CLVSQ | Clovis Oncology Inc | 2019-08-20 | director |
OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
ATYR | aTyr Pharma Inc | 2015-05-06 | director & 10 percent owner |
2019-05-03 | 10 percent owner | ||
2018-08-21 | 10 percent owner | ||
2017-12-18 | 10 percent owner | ||
2017-12-11 | 10 percent owner | ||
2016-11-01 | 10 percent owner | ||
2016-09-09 | 10 percent owner | ||
2013-09-24 | 10 percent owner | ||
2016-03-02 | 10 percent owner | ||
2015-06-24 | 10 percent owner | ||
2013-07-01 | 10 percent owner | ||
2014-11-19 | 10 percent owner | ||
2014-10-15 | 10 percent owner | ||
2013-10-29 | 10 percent owner | ||
2014-08-12 | 10 percent owner | ||
2014-07-31 | 10 percent owner | ||
2014-05-21 | director & 10 percent owner | ||
2014-05-01 | 10 percent owner | ||
2014-03-17 | 10 percent owner | ||
2011-06-02 | 10 percent owner | ||
2013-11-13 | 10 percent owner | ||
2013-01-18 | 10 percent owner | ||
2013-01-14 | 10 percent owner | ||
2011-12-22 | 10 percent owner | ||
2006-05-09 | director & 10 percent owner | ||
2006-12-06 | director & 10 percent owner | ||
2006-04-12 | 10 percent owner | ||
2004-06-25 | 10 percent owner | ||
2016-10-05 | 10 percent owner |
James C Blair Latest Holdings Summary
James C Blair currently owns a total of 10 stocks. Among these stocks, James C Blair owns 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) as of August 20, 2010, with a value of $54 Million and a weighting of 65.04%. James C Blair owns 825,323 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 26.37%. James C Blair also owns 2,102,188 shares of Esperion Therapeutics Inc (ESPR) as of July 1, 2013, with a value of $6 Million and a weighting of 7.05%. The other 7 stocks Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Orexigen Therapeutics Inc (OREXQ) , Clovis Oncology Inc (CLVSQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) , NuVasive Inc (NUVA) have a combined weighting of 1.54% among all his current holdings.
Latest Holdings of James C Blair
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACHN | Achillion Pharmaceuticals Inc | 2010-08-20 | 8,032,129 | 6.76 | 54,297,192 |
ZGNX | Zogenix Inc | 2010-11-29 | 825,323 | 26.68 | 22,019,618 |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 2,102,188 | 2.80 | 5,886,126 |
ALIM | Alimera Sciences Inc | 2011-06-02 | 279,297 | 3.01 | 840,684 |
OCRX | Ocera Therapeutics Inc | 2013-07-15 | 246,386 | 1.79 | 441,031 |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 301,806 | 0.01 | 1,600 |
CLVSQ | Clovis Oncology Inc | 2019-08-20 | 63,544 | 0.02 | 953 |
NOVCQ | Novation Companies Inc | 2006-05-15 | 1,062,474 | 0.00 | 106 |
RGDO | Regado Biosciences Inc | 2013-08-27 | 2,603,208 | 0.00 | 0 |
NUVA | NuVasive Inc | 2006-12-06 | 0 | 39.75 | 0 |
Holding Weightings of James C Blair
James C Blair Form 4 Trading Tracker
According to the SEC Form 4 filings, James C Blair has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on August 20, 2010, which brought James C Blair around $0.
According to the SEC Form 4 filings, James C Blair has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost James C Blair around $9 Million.
According to the SEC Form 4 filings, James C Blair has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 285,714 shares on July 1, 2013, which cost James C Blair around $4 Million.
More details on James C Blair's insider transactions can be found in the Insider Trading History of James C Blair table.Insider Trading History of James C Blair
- 1
James C Blair Trading Performance
GuruFocus tracks the stock performance after each of James C Blair's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James C Blair is 14.65%. GuruFocus also compares James C Blair's trading performance to market benchmark return within the same time period. The performance of stocks bought by James C Blair within 3 months outperforms 6 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James C Blair's insider trading performs compared to the benchmark.
Performance of James C Blair
James C Blair Ownership Network
Ownership Network List of James C Blair
Ownership Network Relation of James C Blair
James C Blair Owned Company Details
What does Clovis Oncology Inc do?
Who are the key executives at Clovis Oncology Inc?
James C Blair is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .
Clovis Oncology Inc (CLVSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clovis Oncology Inc Insider Transactions
James C Blair Mailing Address
Above is the net worth, insider trading, and ownership report for James C Blair. You might contact James C Blair via mailing address: 5880 Pacific Center Blvd, San Diego Ca 92121-4204.